Liver transplants Injury, Occupational Diseases, Poisoning Liver transplants
Conditions
Interventions
In addition to routine clinical care, patients in the intervention group receive pharmaceutical care services provided by a dedicated hospital pharmacist. The Pharmaceutical Care program usually start
Sponsors
University Hospital Mainz, Pharmacy Department (Germany)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Written informed consent 2. Age 18 years or older 3. First organ transplant 4. Follow-up care at the University Hospital Mainz for the first year after transplantation 5. Administration of oral immunosuppressive therapy as capsule or tablet 6. Literacy (German language)
Exclusion criteria
Exclusion criteria: Patients who are not willing to use the Medication Event Monitoring Systems® (MEMS®)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Compliance with immunosuppressive medication measured by MEMS® for 12 months, starting at discharge. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Compliance with immunosuppressive medication measured by the following: 1.1. Pill counts, performed at each ambulatory visit 1.2. Blood levels, performed at each ambulatory visit 1.3. Questionnaires at baseline, 6 and 12 months 2. Quality of life, measured by the 36-item Short Form health survey (SF-36) at discharge, 6 and 12 months after discharge 3. Patients' knowledge regarding drug therapy, assessed by interviews using a standardized questionnaire at 2 weeks after discharge, at first ambulatory visit and 12 months after discharge 4. Patients' satisfaction with the pharmaceutical care provided, assessed by a questionnaire developed for this trial at discharge | — |
Countries
Germany
Outcome results
None listed